We read with interest the Article by Marin Kollef and colleagues reporting the findings of the ASPECT-NP trial. High-dose ceftolozane–tazobactam was reported to be non-inferior to meropenem in the treatment of nosocomial pneumonia, including ventilator-associated pneumonia.

中文翻译：

---

多利培南用于治疗医院内肺炎和呼吸机相关性肺炎。

我们感兴趣地阅读了Marin Kollef及其同事的文章，报道了ASPECT-NP试验的结果。据报道，大剂量的头孢洛嗪-他唑巴坦在治疗包括呼吸机相关性肺炎在内的医院内肺炎方面不逊于美罗培南。